
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.
Isidró Ferrer
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 3
Closed Access | Times Cited: 16
Isidró Ferrer
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 3
Closed Access | Times Cited: 16
Showing 16 citing articles:
Hypothesis review: Alzheimer's overture guidelines
Isidró Ferrer
Brain Pathology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 41
Isidró Ferrer
Brain Pathology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 41
Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
Félix Bermejo‐Pareja, Teodoro del Ser
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 9
Félix Bermejo‐Pareja, Teodoro del Ser
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 9
A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories
Simon Duchesne, Louis‐Simon Rousseau, Florence Belzile-Marsolais, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 3, pp. 843-856
Open Access | Times Cited: 5
Simon Duchesne, Louis‐Simon Rousseau, Florence Belzile-Marsolais, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 3, pp. 843-856
Open Access | Times Cited: 5
CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
Mohamad Sultan Khan, Nousheen Qureshi, Rehan Khan, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Mohamad Sultan Khan, Nousheen Qureshi, Rehan Khan, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
The unique neuropathological vulnerability of the human brain to aging
Isidró Ferrer
Ageing Research Reviews (2023) Vol. 87, pp. 101916-101916
Open Access | Times Cited: 11
Isidró Ferrer
Ageing Research Reviews (2023) Vol. 87, pp. 101916-101916
Open Access | Times Cited: 11
Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging
Isidró Ferrer
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. s1, pp. S153-S164
Open Access | Times Cited: 3
Isidró Ferrer
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. s1, pp. S153-S164
Open Access | Times Cited: 3
Alzheimer’s Disease Neuropathological Change in Aged Non-Primate Mammals
Isidró Ferrer
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8118-8118
Open Access | Times Cited: 2
Isidró Ferrer
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8118-8118
Open Access | Times Cited: 2
Compensatory Mechanisms in Early Alzheimer’s Disease and Clinical Setting: The Need for Novel Neuropsychological Strategies
Eduardo Torrealba, Norka Aguilar-Zerpa, Pilar García-Morales, et al.
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 513-525
Open Access | Times Cited: 6
Eduardo Torrealba, Norka Aguilar-Zerpa, Pilar García-Morales, et al.
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 513-525
Open Access | Times Cited: 6
Proteostatic modulation in brain aging without associated Alzheimer’s disease-and age-related neuropathological changes
Pol Andrés‐Benito, Ignacio Íñigo-Marco, Marta Brullas, et al.
Aging (2023) Vol. 15, Iss. 9, pp. 3295-3330
Open Access | Times Cited: 5
Pol Andrés‐Benito, Ignacio Íñigo-Marco, Marta Brullas, et al.
Aging (2023) Vol. 15, Iss. 9, pp. 3295-3330
Open Access | Times Cited: 5
Historical review: The golden age of the Golgi method in human neuropathology
Isidró Ferrer
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 6, pp. 375-395
Closed Access | Times Cited: 1
Isidró Ferrer
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 6, pp. 375-395
Closed Access | Times Cited: 1
Pulse Feature-Enhanced Classification of Microalgae and Cyanobacteria Using Polarized Light Scattering and Fluorescence Signals
Ran Bi, Jianxiong Yang, Chengqi Huang, et al.
Biosensors (2024) Vol. 14, Iss. 4, pp. 160-160
Open Access | Times Cited: 1
Ran Bi, Jianxiong Yang, Chengqi Huang, et al.
Biosensors (2024) Vol. 14, Iss. 4, pp. 160-160
Open Access | Times Cited: 1
Gut Microbiota and Alzheimer's Disease: Exploring Natural Product Intervention and the Gut–Brain Axis for Therapeutic Strategies
Jajati K. Pasupalak, Prabha Rajput, Girdhari Lal Gupta
European Journal of Pharmacology (2024), pp. 177022-177022
Closed Access | Times Cited: 1
Jajati K. Pasupalak, Prabha Rajput, Girdhari Lal Gupta
European Journal of Pharmacology (2024), pp. 177022-177022
Closed Access | Times Cited: 1
Brain aging and Alzheimer’s disease, a perspective from non-human primates
Isidro Ferrer
Aging (2024)
Open Access | Times Cited: 1
Isidro Ferrer
Aging (2024)
Open Access | Times Cited: 1
Respiratory Dysfunction in Epileptic Encephalopathies: Insights and Challenges
Muhammad Ali Khan, Shah Dev, Maneesha Kumari, et al.
Cureus (2023)
Open Access | Times Cited: 2
Muhammad Ali Khan, Shah Dev, Maneesha Kumari, et al.
Cureus (2023)
Open Access | Times Cited: 2
Subjective cognitive decline and cerebral-cognitive reserve in late age
A. Sidenkova, Vittorio Calabrese, Mario Tomasello, et al.
Translational Medicine of Aging (2023) Vol. 7, pp. 137-147
Open Access | Times Cited: 1
A. Sidenkova, Vittorio Calabrese, Mario Tomasello, et al.
Translational Medicine of Aging (2023) Vol. 7, pp. 137-147
Open Access | Times Cited: 1
Transgenic amyloid precursor protein mouse models of amyloidosis. Incomplete models for Alzheimer's disease but effective predictors of anti‐amyloid therapies
David Morgan, Bruce T. Lamb
Alzheimer s & Dementia (2023) Vol. 20, Iss. 2, pp. 1459-1464
Open Access | Times Cited: 1
David Morgan, Bruce T. Lamb
Alzheimer s & Dementia (2023) Vol. 20, Iss. 2, pp. 1459-1464
Open Access | Times Cited: 1